Lexaria Bioscience EPS Diluted from Other Gain/Loss (Quarterly) Insights

Lexaria Bioscience Corp. (LEXX)

0.7052 +0.03 (+4.47%) USD | NASDAQ | Mar 04, 16:00

0.7052 0.00 (0.00%) After-Hours: 16:22

View EPS Diluted from Other Gain/Loss (Quarterly) for LEXX.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View EPS Diluted from Other Gain/Loss (Quarterly) Chart

Start Trial

View Historical Data

Start Trial

View EPS Diluted from Other Gain/Loss (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View EPS Diluted from Other Gain/Loss (Quarterly) Benchmarks

Start Trial

Oncolytics Biotech, Inc.	--
Aurinia Pharmaceuticals, Inc.	--
Edesa Biotech, Inc.	--
Xenon Pharmaceuticals, Inc.	--
ProMIS Neurosciences, Inc.	--